https://www.pharmacompass.com/ daily 1.00 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/renaissance-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/3m-company yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/aaipharma-services-corp yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/abbott-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/abbvie-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/abic-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/acino-pharma-ag yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/acs-dobfar-spa yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/actavis-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/air-liquide-group yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/air-liquide-healthcare-america-corp yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ajanta-pharma-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/akorn-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/alembic-pharmaceuticals-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/alkaloida-chemical-company-zrt yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/alkermes-plc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/allergan-aesthetics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/altaire-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/amneal-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/amphastar-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/anchen-pharmaceutical-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/angelini-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ani-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/antibiotice yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/apotex-fermentation-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/apotex-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/appco-pharmaceutical-corp yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/aspen-pharmacare-holdings yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/assia-chemical-industries-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/astrazeneca yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/aurobindo-pharma-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/aurolife-pharma-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/aveva-drug-delivery-sytems-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/b-braun-medical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/banner-pharmacaps-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/barr-laboratories-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bausch-lomb-incorporated yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/baxter-healthcare-corporation yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bayer-ag yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/becton-dickinson yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/belcher-pharmaceuticals-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/beximco-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/biocon yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/boehringer-ingelheim-gmbh yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/zydus-lifesciences yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/caraco-pharmaceutical-laboratories-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/carlsbad-technology-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/catalent-pharma-solutions yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/century-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/changzhou-pharmaceutical-factory yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/chartwell-pharmaceuticals-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/chattem-chemicals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/chemi-spa yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/chemische-fabrik-berg yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cr-double-crane-pharmaceuticals-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cipla yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/colgate-palmolive yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/concord-biotech yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/contract-pharmacal-corporation yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/corepharma-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/corium yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/crown-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/daiichi-sankyo yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/daito-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/deva-holding-as yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/dexcel-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/douglas-cdmo yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/dr-reddys-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/eirgen-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/elite-laboratories-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/emcure-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/epic-pharma-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ethypharm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/exela-pharma-sciences-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/e-z-em-canada-inc-dba-therapex yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/fdc-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ferndale-laboratories-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ferring-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/fertin-pharma-as yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/finetech-pharmaceutical-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/flamingo-pharmaceuticals-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/forest-laboratories-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/fougera-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/fresenius-kabi-ab-brunna yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/future-pak-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/gw-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ge-healthcare-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/genentech yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/vintage-pharmaceuticals-charlotte yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/gland-pharma-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/gsk yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/granules-india-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/guardian-drug-company yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hainan-poly-pharm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/halocarbon-products-corp yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hangzhou-minsheng-binjiang-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hangzhou-zhongmei-huadong-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/harman-finochem yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/helsinn-advanced-synthesis yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hetero-drugs yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hikma-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hisamitsu-pharmaceutical-co-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hi-tech-pharmacal-co-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hospira-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hybio-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/idt-australia-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/igi-labs-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/impax-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ims-srl-micronizzazioni yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/indoco-remedies-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/brightgene-bio-medical-technology-coltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/insys-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/intas-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/invagen-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/inventia-healthcare-private-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ipca-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/istituto-biochimico-italiano-giovanni-lorenzini-spa yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/italfarmaco-spa yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ivax-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/jacobus-pharmaceutical-company-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/janssen-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/jerome-stevens-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hansoh-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/jiangsu-hengrui-medicine yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/jubilant-cadista-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/jubilant-draximage-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/jubilant-generics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/krka yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kvk-tech-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/perrigo-company-plc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/grifols-international yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lannett-company-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/laurus-labs yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/liaoning-chengda-biotechnology-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/livzon-group-fuzhou-fuxing-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lotus-pharmaceutical-co-ltd-nantou-plant yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/luitpold-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lupin-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lyne-laboratories-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/macleods-pharmaceuticals-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mallinckrodt-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/marksans-pharma-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mcguff-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/meda-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/medefil-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/merck-co yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/merro-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/metrics-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/micro-labs-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mikart yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mirror-pharmaceuticals-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mission-cdmo yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/morton-grove-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/msn-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mundipharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mustafa-nevzat-ilac-sanayi-a-s yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mutual-pharmaceutical-company-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/viatris yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nang-kuang-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nanjing-king-friend-biochemical-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/natco-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/navinta yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/neos-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nephron-pharmaceuticals-corporation yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nesher-pharmaceuticals-usa-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nexgen-pharma-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/norwich-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nostrum-laboratories-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/novartis-pharmaceuticals-corporation yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/novast-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/novel-laboratories-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/noven-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/orchid-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/orient-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/orion-corporation yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/osmotica-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/p-and-l-development-of-new-york-corporation yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/panacea-biotec-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/par-formulations-private-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/par-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/patheon yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pfizer-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pharmachemie-b-v yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pharmacosmos-as yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pharmadax yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pharmaforce-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/piramal-enterprises-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pliva-hrvatska yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/precision-dermatology-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/purdue-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/purdue-pharmaceuticals-lp yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/qilu-antibiotics-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/qilu-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/recordati yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/reliance-life-sciences-private-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/rhodes-technologies-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/laboratorios-farmaceuticos-rovi yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/rubicon-research-pvt-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sandoz-b2b yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sanochemia-pharmazeutika-gmbh yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/savior-lifetec-corporation yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sciegen-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/scinopharm-taiwan-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/shandong-xinhua-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/shanghai-desano-bio-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/shanghai-hengrui-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/shenzhen-techdow-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/shilpa-medicare yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sicor-de-mexico-s-a-de-c-v yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sigmapharm-laboratories-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sovereign-pharmaceuticals-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/square-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/standard-chem-pharm-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/stason-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/steri-pharma-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sterling-spa yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sun-pharmaceutical-industries-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sunshine-lake-pharma-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/synthon-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/taro-pharmaceutical-industries yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/tedor-pharma-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/teva-pharmaceutical-industries yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/the-ritedose-corporation yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/tolmar yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/torrent-pharmaceuticals-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/tris-pharma-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/twi-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ucb-pharma-sa yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ultratab-laboratories-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/umedica-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/unichem-laboratories-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/unique-biotech-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/upsher-smith-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/usv-private-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bausch-health yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/vista-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/visum-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/warner-chilcott-company-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/west-ward-pharmaceutical-corp yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/wockhardt yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/xellia-pharmaceuticals-aps yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/xttrium-laboratories-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/yaopharma-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/yung-shin-pharmaceutical-industrial yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/zambon-switzerland yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/zhejiang-hisun-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/zhejiang-jiuzhou-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/zhejiang-medicine-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/zhejiang-xianju-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/eurofarma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/molnlycke-health-care-ab yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/aft-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/extrovis-ag yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/royal-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/alvotech yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/amneal-deutschland-gmbh yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bio-thera-solutions yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/biofrontera yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/urogen-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/satsuma-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lg-chem yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hugel yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/tapi-technology-api-services yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/luoxin-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/q-biomed yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/viela-bio yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sofie-biosciences yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/genmab yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mycovia-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/puma-biotechnology yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/amylyx-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/aurinia-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/xcovery yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/arcutis-biotherapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/heron-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cosmo-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/vkt-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nuvation-bio yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/agios-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/axsome-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/biocryst-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cycle-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/deciphera-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/formycon yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/knight-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/phathom-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/verrica-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/omeros yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/tg-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/merus yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mirum-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/alk yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/epizyme yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/csl-vifor yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kashiv-biosciences yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/akeso yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/veloxis-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/atral yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ardelyx yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cytokinetics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/intra-cellular-therapies yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/immunitybio yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/owp-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bridgebio-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bioxcel-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mediwound yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/biocorrx yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/acerus-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/botanix-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/assertio-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/karyopharm-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/global-blood-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/clinuvel-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/harmony-biosciences yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/iterum-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/marinus-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/evofem-biosciences yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/acer-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/syndax-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kalvista-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/xeris-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/trevena yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/avadel-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/averitas-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/geron yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/oxurion yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/calliditas-therapeutics-ab yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mc2-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/immunogen yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/galderma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/acacia-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/precision-biosciences yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/baudax-bio yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/stemline-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/tarsus-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/delcath-systems yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/eyepoint-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cormedix yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/afaxys-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/elorac yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/aprecia-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/innocoll-pharmaceuticals-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ubi-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/acrotech-biopharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/aytu-bioscience yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/burke-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/eyenovia yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ocular-therapeutix yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kura-oncology yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/fennec-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/la-jolla-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ars-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/american-regent yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/meitheal-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pl-developments yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/rhythm-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/intrabio yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/xiromed yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/zennova-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/alfasigma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cumberland-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/biopharm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kiniksa-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/vero-biotech yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/shanghai-henlius-biotech yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/neurocrine-biosciences yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/catalyst-biosciences yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/key-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pharmaco yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ridgeback-biotherapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/napo-eu yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kd-pharma-group yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/madrigal-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/checkpoint-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pharming yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/insmed yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/soleno-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/r-pharm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/alpha-cognition yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kindeva-drug-delivery yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lgm-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/strongbridge-biopharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/adamas-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/day-one-biopharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/chiesi-group yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/braeburn yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/national-institutes-of-health yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/shorla-oncology yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ironshore-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/dompe-farmaceutici yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/plano yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/adalvo yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/scpharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/telix-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/evive-biotech yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/exeltis yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/on-target-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/alimera-sciences yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/galt-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/60-degrees-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/radius-health yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/eversana yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/liquidia-corporation yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/catalyst-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/elusys-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/epi-health yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/custopharm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nuvo-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/graviti-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/yiling-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/orasis-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/juvise-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/neurelis yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/travere-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/endo-international yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/seagen yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/collegium-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/avion-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/zhejiang-lepu-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lantheus-holding yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nx-development-corp yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/linde yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cp-pharm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/adienne yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/advanced-accelerator-applications yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/applied-analytics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/memorial-sloan-kettering-cancer-center yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bwx-technologies yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/denmat-dental yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/foundation-consumer-healthcare yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lxo-group yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/stryker yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/rexall-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/tersera-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/uspharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/zo-skin-health yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/merz-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ipharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/genus-lifesciences yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cooper-surgical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ncm-usa yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hameln-rds yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/suven-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/biovail-corporation yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ut-southwestern-medical-center yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/chiron yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/marius-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/glaukos yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/blue-earth-technology yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/florida-pharmaceutical-products yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/galephar-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nivagen yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/rosemont yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/advanz-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/slayback-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/weill-cornell-medicine yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/primus-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/renew-biopharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/beijing-tide-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bbraun yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hexcel-corporation yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/anima-medical-centre yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/jiangsu-simcere-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/acme-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/secura-bio yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/scilex-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/glenwood yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/isologic-innovative-radiopharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/aytu-biopharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ibsa-institut-biochimique yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kowa-pharmaceuticals-america yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nrx-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lenz-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/annora-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/university-of-california yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/organon yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/altana yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ambix-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/anabolic-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/belmar-pharma-solutions yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/general-electric yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/md-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/adhera-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/solaris-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/biofidelity yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/agl-welding-supply yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/abon-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/agnitio yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ah-robins yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ailex-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/allegiance-healthcare-solutions yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/almaject yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/alphathera yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/altathera yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/althera yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/alza-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/am-therapy yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/american-welding-gas yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/amici-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/amring-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/amivas yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/american-massage-therapy-association yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/anda-repository yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/anbison yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/a-ox-welding-supply yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ar-holding yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/arcum yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/arise-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ascend-labs yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bf-ascher-company yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ascot-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/aspiro-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/athem-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/avondale-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/azurity-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sanofi yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/padagis yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bell-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/belmora yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/msd-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bioglan yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/biomedical-research-foundation yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/chamberlain-group yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/copley-scientific yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/carlisle yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/dell-environmental-monitoring-centre yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/edenbridge-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/everylife-technologies yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hamilton yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/huaren-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/innogenix yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/interpharm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/oxford-pharm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pharmaderm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pioneer-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/quagen-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/savage-lab yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/solo-pak yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/winder-lab yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/dey yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/discovery-therapy yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/qingdao-baheal-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/rk-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/indchemie yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kenton yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/fison yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/saptalis-pharm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sinotherapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/spil yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/tagi-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/tulex-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/vitruvias-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sunny-pharmtech yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/blairex-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bluline yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bpi-labs yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hot-shots-nuclear-medicine yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sperti yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pharmtak yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/phoenix-environmental-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pharmavite yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/currax yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/chasechem-industries yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lp-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/camall yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ck-supply yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/dfb-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/medical-and-dental-defence-union-of-scotland yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/norco-medical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/novelgenix yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/praxgen yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/central-welding-supply yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cisbio yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/consolidated-midland-corp yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cytogen yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/dash-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/dupuy-oxygen yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/dynapharm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/e5-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/franklin yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/genbiopro yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hbt-labs yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/puracap yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ic-targets yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ilmo-products-company yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/intersect-ent yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/matheson-gas-professionals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kinapse yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/novatech yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nukemed yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nexair yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/prasco-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/microbix-biosystems yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ross-lab yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/international-isotopes yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/intra-sana-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/iomed yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ionetix yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lifelabs yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/liss-america yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/matrix-medical-network yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mayer-labs yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mericon yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/metabolic-solutions yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/metacel-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/milla-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/oxarc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/paragon-bioteck yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pennex-aluminum yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pharmaventures yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pharmalogic yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pharmics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/purity-cylinder-gases yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/rafa yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/resilia-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/roberts-oxygen-company yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/schiff-company yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/spectra-medical-devices yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sprout-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/st-renatus yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/stuart-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/teikoku-pharma-usa yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/tg-united yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/universal-industrial-gases yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/vesselon yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/westair-gases-equipment yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/zurex-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/purple-biotech yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/the-medicines-patent-pool yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/elitepharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/medrx yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cosette-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/dizal-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/overseas-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/vgyaan-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/rvl-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/senores-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ayana-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/healthcare-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/i3-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/persion-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/propel-pharmacy yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/rainbow-medical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sarfez-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/slate-run-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sola-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/tripoint-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/westminster-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/javelin-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/wisconsin-medical-cyclotron-radiopharmacy yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/middlesex-gases yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/orbion-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/harm-reduction-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/omsav-pharma-research yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/teyro-labs yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/eskayef-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/knack-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/rayner yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/theragnostics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nobelpharma-america yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/orphalan yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/thea-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/renata-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/carnegie-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/continental-carbonic-products yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/creekwood-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/emed-medical-company yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/general-air-service-supply yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/long-grove-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/harrow yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/accord-biopharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/haleon yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/difgen yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pure-source yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/steriscience yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/absolute-air yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hatchtech-pty-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kindos-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/laurus-generics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kv-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/zenara-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/karo-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/key-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/capstone-development-services yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/theracosbio yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/the-j-molner-company yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/zevra-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pangea-biomed yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/agepha-pharma-us yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mmb-healthcare yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kw-griffen yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/guangzhou-novaken-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/healthpoint yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/legacy-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mainpointe-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/medicines-development-for-global-health yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/medi-radiopharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/usantibiotics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/misemer-pharmacetical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/omnivium-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/patrin-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/penn-life-sciences yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/polarean yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/protega-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sciarra-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/united-research-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/uluru yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/topiderm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/theragen yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/women-first-healthcare yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/zameer-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/meridian-bioscience yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pharmos yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pulmoflow yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pyros-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/waylis-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/biocon-biologics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/saba-la-sanayii-ve-ticaret yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lib-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sumitomo-pharma-america yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/gensco-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/fabre-kramer-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/strides-pharma-science yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bostal yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/onconetix yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/maia-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/seasons-biotechnology yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/everest-life-sciences yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/tanvex-biopharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/avyxa yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lacer yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/theravia yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/solubiomix yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/tilde-sciences yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ocuvex-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/corstasis-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sq-innovation yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/scienture yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/fosun-wanbang-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/prm-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/norvium yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/anthea-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bamf-health yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lumicell yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/h-lundbeck-as yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pd-partners yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/instapill yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nippon-shinyaku yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/concordia-labs-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nestle-health-sciences-sa yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kyowa-kirin yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cspc-pharmaceutical-group yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nordic-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/covidien-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sucampo-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/jiangsu-chia-tai-tianqing-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/f-hoffmann-la-roche yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/eisai yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/china-resources-pharmaceutical-group yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/fresenius-kabi-usa-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/fresenius-medical-care yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/glenmark-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mitsubishi-tanabe-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/otsuka-america-pharmaceutical-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/par-sterile-products yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ecr-pharmaceuticals-co-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sagent-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/udl-laboratories-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/alphapharm-pty-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/shanghai-zhongxi-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lek-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/leading-pharma-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/shijiazhuang-yiling-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ligand-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/alexion-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/alliance-pharmaceutical-company yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/airgas-usa-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/almirall yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/armstrong-manufacturing-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/atnahs-pharma-uk-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/banner-life-sciences-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/btg-international-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/celltrion yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cheplapharm-arzneimittel-gmbh yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/dutch-ophthalmic-research-center-international-bv yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/gemini-packaging-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hansamed-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hill-dermaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/linde-canada-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/medexus-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/medline-industries-incorporated yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/medunik-canada yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/niagara-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/numark-laboratories-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/parnell-technologies-pty-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/praxair-canada-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/prestige-consumer-healthcare yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/societal-cdmo yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sage-products-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/smith-nephew-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sterimax-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sunstar-americas-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/wendt-labs yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cobalt-pharmaceuticals-company yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/emd-serono yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/alfred-e-tiefenbacher-gmbh yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sichuan-qingmu-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/reyoung-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/rising-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cmg-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sterinova-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sawai-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/invatech-pharma-solutions-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/wes-pharma-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/eci-pharmaceuticals-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cmp-pharma-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/adare-pharma-solutions yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cadila-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/fera-pharmaceuticals-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/angus-chemical-company yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mankind-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/brooks-laboratories-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cisen-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/concordia-international yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/jmc-corporation-kr yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kamata-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/laboratorios-salvat yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/icon-plc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/quantum-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/luye-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/emergent-biosolutions yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/regeneron-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/arrow-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/calgon-carbon-corporation yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nal-pharmaceutical-group-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/aiping-pharmaceutical-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/novitum-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/esjay-pharma-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/verity-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/samsung-bioepis yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/dastech-international-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/west-pharmaceutical-services yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/innopharmax yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ingenus-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/woodward-pharma-services yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/casi-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ionis-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/crinetics-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/icu-medical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/apil yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bionpharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/quad-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/aucta-pharmaceuticals-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/zealand-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/aquestive-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/agile-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/indivior yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/blueprint-medicines yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/meridian-medical-technologies yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/coherus-biosciences yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/chimerix yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ironwood-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ascendis-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/stealth-biotherapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kramer-laboratories-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lexicon-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kyrex-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/akebia-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/amicus-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/melinta-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/newron-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/paratek-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/intercept-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ptc-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/piramal-pharma-solutions yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/morphosys yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/skyepharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/tetraphase-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sage-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/beone-medicines yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/adapt-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/civica-rx yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/x4-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/immunomedics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/springworks-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/medicines360 yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/y-mabs-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/siga-technologies yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/arrowhead-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/besins-healthcare yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/entasis-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/shield-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/verastem-oncology yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/innate-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/rigel-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/aclaris-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kala-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/adc-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/verona-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ratiopharm-gmbh yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/aveo-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/novimmune-sa yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/loxo-oncology-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sarepta-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/idorsia-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/teligent-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/immunocore yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/argenx yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/alnylam-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/tonix-pharmaceuticals-holding-corp yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/impel-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/revance-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/macrogenics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/esperion-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/akcea-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/crescita-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/evolus yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/novugen yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/eton-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/oyster-point-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/apellis-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/3d-imaging-drug-design-and-development-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/abraxis-pharm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/academic-pharms yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/accelrx-labs yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/accord-healthcare yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/acella-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/aeterna-zentaris yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/air-products-fr-38070-saint-quentin-fallavier yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/alcon-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/alkopharma-usa yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/allerquest yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/allied-pharma-technologies yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/almatica-pharma-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/alra yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/amag-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/amarin yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/amgen-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/anbex yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/andrx-labs-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/antares-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/apgdi yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/app-pharms yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/arbor-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/arco-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/areva-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ascend-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/atlas-pharms-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/aton-pharma-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/avanir-pharms yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/avanthi-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/avent yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/avid-radiopharms-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bajaj-healthcare yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bedford-labs yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/biocodex yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/biodelivery-sciences yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/biogen yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/biomarin-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bracco yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/braintree-labs yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bristol-laboratories-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cadence-pharms yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/centocor yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cephalon-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/chiesi-usa-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/chirhoclin yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cipher-pharms-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/citius-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/clinigen-group yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/clonmel-hlthcare yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/coastal-pharms yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/corcept-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cornerstone-therap yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/covis-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cppi-cv yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/csl-behring yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cubist-pharms-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cumberland-pharms yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cypress-pharm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/daito-corp yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/danco-labs-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/dava-pharms-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/davis-and-geck yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/delcor-asset yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/dentsply-pharm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/depomed-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/dialysis-sups yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/digestive-care-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/duchesnay yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/duramed-pharms-barr yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/eagle-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/eastman-kodak yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ecolab-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/edison-theraps-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/eisai-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/emmaus-life-sciences yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/endo-pharm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/essential-isotopes yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/eurand-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/exelixis yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/falcon-pharms yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/feinstein-institutes yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/galderma-labs-lp yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/galen-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/galen-specialty yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/gavis-pharms yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/gd-searle-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/guerbet yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/halozyme-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hanford-gc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/avet-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/heyl-chemisch yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hope-pharms yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hq-spclt-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hq-speclt-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hra-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/iba-molecular yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/iceutica-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/incyte-corporation yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/indicus-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/insight-pharms yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/interpharma-praha-as yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ipsen yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/iso-tex yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/isotex yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/jazz-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kaleo-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kowa-india yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kreitchman-pet-center yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/kudco-ireland yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/esteve-quimica yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lantheus-medical-imaging yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lavipharm-labs yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lnk yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/loreal-usa yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lukare-medical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/lunan-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mcprf yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/the-medicines-company yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/medicis-pharmaceutical-corp yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/medicure yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/medtech-prods yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/midwest-medical-isotopes-llc-cyclotron-div yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/moberg-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/msd-intl-gmbh yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/new-river-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nextwave-pharms yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nexus-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/northstar-medical-radioisotopes yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nova-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/novo-nordisk yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nps-pharms-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/nycomed-austria-gmbh yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/odyssey-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/olta-pharmaceuticals-corp yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ony-biotech yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/onyx-pharms yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/orapharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pacira-biosciences yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pai-pharmaceutical-associates yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/petnet yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pharm-assoc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pharmacyclics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pharmaessentia yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pharmaxis yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/photocure yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pierrel yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pinnacle-biologics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pld-acquisitions yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pliva-lachema yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/plx-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pohl-boskamp yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/polymedica yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/powder-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pragma-pharms-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/precision-dose yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/prinston yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/procter-and-gamble yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/prof-dspls yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/promius-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/provensis yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/provepharm-life-solutions yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/provident-pharm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/puracap-pharm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/purepac-pharm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pvt-form yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/qol-medical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/questcor-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/reckitt-benckiser yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/rempex-pharms-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/rhodes-pharmaceuticals-lp yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/riconpharma-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/rockwell-medical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/romark yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/rouses-point-pharms yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/roxane yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/rp-scherer-gmbh-co-kg yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/salix-pharms yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/samson-medical-technologies yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/santen-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sb-pharmco yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/beijing-sciecure-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/scios-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sebela-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/septodont-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/seton-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/shionogi yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/shire-plc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/shire-human-genetic-therapies-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/shire-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sigma-tau yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sofgen-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/somerset-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/spectrum-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/stiefel yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sunovion-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/supernus-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/swedish-orphan-biovitrum-ab yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/taiho-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/tamarang yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/thepharmanetwork-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/therakos yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/theratechnologies yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/theravance-biopharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/tianjin-tianfa-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/trace-life-sciences-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ucla yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ucsf-rodiopharm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/ultragenyx-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/unichem-pharmaceuticals-usa-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/united-guardian yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/united-therapeutics yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/the-university-of-texas-md-anderson-cancer-center yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/us-worldmeds yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/usl-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/validus-pharms yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/vanda-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/vansen-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/veroscience yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/vertex-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/vertical-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/viiv-healthcare yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/virtus-pharm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/vivus yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/wa-univ-sch-med yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/wilshire-pharms-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/wraser-pharms yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/wusm-cyclotron yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/wyeth-pharmaceuticals-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/xgen-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/yichang-humanwell-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/zydus-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/aizant-drug-research-solutions-pvt-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/alkermes-contract-pharma-services yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/alvogen yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/armor-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/aspen-api yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/astellas-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/athena-pharmaceutiques yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/basf yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/beijing-sl-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/biological-e yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/breckenridge-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/bristol-myers-squibb yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/caplin-point-laboratories-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cardinal-health yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/celgene-corporation yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/chemo yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/cordenpharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/daewoong-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/eli-lilly yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/encube-ethicals-pvt-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/galenicum yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/gedeon-richter yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/genpharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/gilead-sciences yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hainan-shuangcheng-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hec-pharm yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/hubei-gedian-humanwell-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/huons-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/johnson-johnson yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/laboratoires-gilbert yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/servier yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/leo-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mannkind yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mayne-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/mcneil-consumer-health yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/merck-serono yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/methapharm-speciality-pharmaceuticals yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/naari yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/neolpharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/norbrook-laboratories yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/opocrin-spa yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/optimus-pharma yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/otsuka-chemical-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pacific-organics-pvt-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pharmacare-premium yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pharmascience-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/pierre-fabre yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sentiss-pharma-pvt-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/fosun-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/sk-life-science yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/solvay-chemicals-international-s-a yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/specialty-coating-systems-inc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/takeda-pharmaceutical yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/thinq-pharma-cro-pvt-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/viwit-pharmaceuticals-limited yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/world-gen-llc yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/zhejiang-jingxin-pharmaceutical-co-ltd yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/zhejiang-yongning-pharmaceutical-co-lt yearly 0.7 https://www.pharmacompass.com/fdf-licensing-available-formulations-dossiers/zhejiang-yongtai-technology yearly 0.7